Objective measure of treatment outcome in epilepsy

Epilepsia

Volumn 37, Issue 6, 1996, Pages 572-576

  Eslava Cobos, Jorge ^a,b  

^a Inst Neurológico de Colombia   (Colombia)

^b NONE   (Colombia)

Author keywords

Clinimetrics; Seizure frequency; Seizure outcome; Treatment outcome

Indexed keywords

ARTICLE; DECISION MAKING; EPILEPSY; HUMAN; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; TREATMENT OUTCOME;

ALGORITHMS; EPILEPSY; HUMANS; MEDICAL RECORDS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 0029888597     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00611.x     Document Type: Article

References (16)

1. Lammers M, Hekster Y, Keyser A, Renier W, Meinardi H. Clinimetrics in epileptology. Epilepsia 1994;35(suppl 7):S17.
2. Shofer J, Temkin R. Comparison of alternative outcome measures for antiepileptic drug trials. Arch Neurol 1986;43: 877-81.
3. Bourgeois B, Leppik I, Sackellares J, et al. Felbamate: a double blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993;43:693-6.
4. Eslava-Cobos J, Nariño D. Experience with the International League Against Epilepsy proposals for classification of epileptic seizures and the epilepsies and epileptic syndromes in a pediatric outpatient epilepsy clinic. Epilepsia 1989;30:112-5.
5. Eslava-Cobos J. Nariño D. Treatment strategies in epileptic syndromes, in VI Child Neurology World Congress, Buenos Aires, November 8-13, 1992.
6. Patrick S, Berg A, Spencer S. EEG and seizure outcome after epilepsy surgery. Epilepsia 1995;36:236-40.
7. Talwar D, Baldwin M, Hutzler R, Griesemer D. Epileptic spasms in older children: persistence beyond infancy. Epilepsia 1995;36:151-5.
8. Dodrill C, Arnett J, Sommerville K, Sussman N. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36: 164-73.
9. Baram T, Schultz L. ACTH does not control seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 1995;36:174-8.
10. Velisek L, Veliskova J, Ptachewich Y, Shinnar SH, Moshé SL. Effects of MK-801 and phenytoin on flurothyl-induced seizures during development. Epilepsia 1995;36:179-85.
11. Thadani V, Williamson P, Berger R, et al. Successful epilepsy surgery without intracranial EEG recording: criteria for patient selection. Epilepsia 1995;36:7-15.
12. Bourgeois B. Pharmacologic intervention and treatment of childhood seizure disorders: relative efficacy and safety of antiepileptic drugs. Epilepsia 1994;35(suppl 2):S18-23.
13. O'Donoghue M, Duncan J, Sander A. Methodologic problems with assessment of seizure severity. Epilepsia 1994; 35(suppl 7):S95.
14. Vickrey B, Hays R, Engel J, et al. Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol 1995;37:158-66.
15. Vickrey B, Hays R, Rausch R, Sutherling W, Engel J Jr, Brook R. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia 1994;35: 597-607.
16. Cramer J. A clinimetric approach to assessing quality of life in epilepsy. Epilepsia 1993;34(suppl):S8-13.